Andromeda Surgical

We’re excited to announce we were accepted into FDA’s Safer Technologies Program (STeP)! Andromeda’s mission is to empower every surgeon to deliver optimal results to every patient every time. This is great validation that FDA recognizes our technology’s potential to improve surgical safety. We’re looking forward to collaborating with FDA to bring our product’s benefits to patients and surgeons more efficiently through this program. https://lnkd.in/egRZPAy

In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of #AutonomousSurgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s #healthcare experiences into a love of the industry and a drive to help. And finally, MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – #SurgicalRobotics, Medtronic, ResMed, Layoffs and, of course, Baxter International Inc. LISTEN HERE: https://lnkd.in/ez99CDcK

30+ Deep Tech startups pitched yesterday at Boost VC Demo Day 🚀 Ones to watch 👀 Acrylic Robotics led by Chloë Ryan Andromeda Surgical led by Nick Damiano Material led by Gabe Elias Natilus led by Aleksey Matyushev Soarce led by Derek Saltzman

Looking forward to sharing the Andromeda Surgical story at DeviceTalks West on October 16th!

We're excited to welcome Michael Nketiah, MBA, RAC to our team as Chief of Regulatory & Quality! Building products that push the boundaries of surgical robotics requires charting new territory with regulatory bodies, and Michael with his creative, first-principles approach is going to be a huge asset to our team. He brings an outstanding 25-year track record as a regulatory & quality leader in the medtech industry. He will lead US and global regulatory matters including strategy, submissions, and interactions with regulatory authorities. Michael previously held leading regulatory & quality roles at Nexalin Technology, InterVenn Bioscience, Tivic Health, Previvo Genetics, and PROCEPT BioRobotics. At PROCEPT he was responsible for obtaining the initial US FDA De Novo Request grant for the Aquablation System and other global market approvals including Australia, Canada, CE Mark, and New Zealand. 

🎉 We're thrilled by the incredible attention we're receiving at AUA! A big shoutout to the amazing urologists trying out the first robotic HoLEP. If you're here, come find us near the Robotics Theater and see the future of urology in action! Andromeda Surgical Nick Damiano Kartik Tiwari Mishaal Ali, MD Santhi Analytis, Ph.D. Andromeda Surgical #AUA #urology #RoboticHoLEP 🤖🏥

We're excited to be at the AUA! Stop by booth 2322 to explore Androneda Surgical—the newest and only robotic system designed for HoLEP and transurethral procedures. Come see how we're advancing surgical technology right by the robotic theater. Connect with us to learn more! Andromeda Surgical Nick Damiano Kartik Tiwari Mishaal Ali, MD Santhi Analytis, Ph.D. #AUA #InnovationInSurgery #RoboticSurgery

Our first showing at AUA starts tomorrow! Come by booth #2322 and see a demo if you're here. #AUA2024

Happy first birthday to Andromeda Surgical! It's been an eventful year with lots of progress and increasing excitement about what we're building. We set out to develop autonomous robots to make surgery safer, easier, and more efficient. We knew it would be hard and weren't sure our big product vision was even possible, but one year later we're more confident than ever that we can launch something impressive surprisingly fast. First year highlights: * Built fully functional robot and demoed successfully for a group of the world's leading urologists in just 9 months * Finalizing AI & other software features for an unveiling at AUA next month, then launching into the clinic not long after * Met most of the leading global experts in our beachhead procedure, many of whom have contributed meaningfully to the effort - special shout out to Dr. Fernando Gómez Sancha who has been a game changer * Closed oversubscribed pre-seed and seed rounds with incredibly supportive investors Amazing work from Kartik Tiwari, Rami Abukhalil, Mishaal Ali, MD, Kevin Spevak, Apurv Tiwari, and other team members who have contributed in big and small ways. Stay tuned for more exciting updates in year two, and come see us at booth #2322 at #AUA24 if you're there in May.

The Andromeda team is at #EAU24 in Paris! Reach out to us at info@andromedasurgical.com if you're interested to meet.